1·Methods Thrombosis was observed with arteriovenous shunt thrombus model in rat;
方法用动静脉短路血栓形成模型观察血栓形成；
2·Objective to explore the curative effect of hepatocellular carcinoma with arteriovenous shunt treated with interventional.
目的观察介入治疗对肝癌合并肝动脉-静脉瘘患者的作用。
3·Arteriovenous shunt, as a complication of RFA, can cover local recurrence because of hepatic hypo perfusion and abnormal portal perfusion.
局部肝动脉门静脉瘘是射频治疗的并发症，常因局部肝动脉灌注不足和门静脉异常灌注，掩盖局部复发征象。
4·AIM To study the effect of 3,4 oxo isopropylidene shikimic acid (ISA) against arteriovenous shunt and middle cerebral artery thrombosis (MCAT) in rats.
目的研究异亚丙基莽草酸（ISA）对大鼠动静脉环路血栓、大脑中动脉栓塞及血小板聚集的对抗作用及机制。
5·Method: making two types of whole animal models by causing rats' arteriovenous shunt thrombosis and giving electric stimulus to rats' common carotid artery to bring on thrombosis.
方法：采用大鼠动-静脉旁路血栓形成法和电刺激大鼠颈总动脉造成血栓形成两种整体动物血栓形成模型。
6·Results: of 32 cases of HCC with arteriovenous fistula, 12 cases revealed distinct fistula, 17 showed fine shunt and 3 indefinite fistula.
结果：32例肝癌伴肝动静脉瘘，其中12例见明显的瘘道，17例见分流通道纤细，3例无确切的分流通道。